Skip to main content
Top
Published in: Journal of Gastroenterology 3/2024

Open Access 23-01-2024 | Familial Adenomatous Polyposis | Original Article—Alimentary Tract

Risk of gastric adenoma and adenocarcinoma in patients with familial adenomatous polyposis in Japan: a nationwide multicenter study

Authors: Kazuhito Sasaki, Kazushige Kawai, Hiroaki Nozawa, Soichiro Ishihara, Hideyuki Ishida, Keiichiro Ishibashi, Yoshiko Mori, Satoki Shichijo, Yasuhiro Tani, Yoji Takeuchi, Akiko Chino, Misato Takao, Kenji Fujiyoshi, Takaaki Matsubara, Yasuyuki Miyakura, Fumitaka Taniguchi, Tatsuro Yamaguchi, Kohji Tanakaya, Naohiro Tomita, Yoichi Ajioka

Published in: Journal of Gastroenterology | Issue 3/2024

Login to get access

Abstract

Background

Patients with familial adenomatous polyposis (FAP) have an increased risk of developing gastric neoplasms. However, the clinical course of FAP with these gastric lesions has not yet been fully clarified. The present study aimed to clarify the changes in the incidence risk of developing gastric adenoma or gastric cancer during the lifespan of patients with FAP.

Methods

Four hundred forty-three patients with data regarding gastric adenoma and gastric cancer retrospectively registered in a nationwide Japanese multicenter study were enrolled. The cumulative incidences and hazard rates (HRs) of gastric neoplasms were evaluated.

Results

The cumulative incidence rates in 50-year-old patients with FAP were 22.8% for gastric adenoma and 7.6% for gastric cancer, respectively. No significant association was found between gastric neoplasms and the colonic phenotype. The peak age for the HR of gastric adenoma was 65 years, with the highest HR (0.043). Regarding the incidence of gastric cancer, the HR increased moderately up to the age of 40 years, but the increase accelerated from the age of 50 years (HR = 0.0067).

Conclusion

Careful surveillance of the upper gastrointestinal tract in elderly patients with FAP, such as shortening the interval of follow-up according to age, may be helpful for early diagnosis of gastric cancer.
Appendix
Available only for authorised users
Literature
1.
go back to reference Groden J, Thliveris A, Samowitz W, et al. Identification and characterization of the familial adenomatous polyposis coli gene. Cell. 1991;66:589–600.CrossRefPubMed Groden J, Thliveris A, Samowitz W, et al. Identification and characterization of the familial adenomatous polyposis coli gene. Cell. 1991;66:589–600.CrossRefPubMed
2.
go back to reference Joslyn G, Carlson M, Thliveris A, et al. Identification of deletion mutations and three new genes at the familial polyposis locus. Cell. 1991;66:601–13.CrossRefPubMed Joslyn G, Carlson M, Thliveris A, et al. Identification of deletion mutations and three new genes at the familial polyposis locus. Cell. 1991;66:601–13.CrossRefPubMed
3.
go back to reference Kinzler KW, Nilbert MC, Su LK, et al. Identification of FAP locus genes from chromosome 5q21. Science. 1991;253:661–5.ADSCrossRefPubMed Kinzler KW, Nilbert MC, Su LK, et al. Identification of FAP locus genes from chromosome 5q21. Science. 1991;253:661–5.ADSCrossRefPubMed
4.
go back to reference Bulow S, Faurschou Nielsen T, Bulow C, et al. The incidence rate of familial adenomatous polyposis Results from the Danish Polyposis Register. Int J Colorectal Dis. 1996;11:88–91.CrossRefPubMed Bulow S, Faurschou Nielsen T, Bulow C, et al. The incidence rate of familial adenomatous polyposis Results from the Danish Polyposis Register. Int J Colorectal Dis. 1996;11:88–91.CrossRefPubMed
5.
go back to reference Murata M, Utsunomiya J, Iwama T, et al. Frequency of adenomatosis coli in Japan. Jinrui Idengaku Zasshi. 1981;26:19–30.CrossRefPubMed Murata M, Utsunomiya J, Iwama T, et al. Frequency of adenomatosis coli in Japan. Jinrui Idengaku Zasshi. 1981;26:19–30.CrossRefPubMed
6.
go back to reference Hyer W, Cohen S, Attard T, et al. Management of Familial Adenomatous Polyposis in Children and Adolescents: Position Paper From the ESPGHAN Polyposis Working Group. J Pediatr Gastroenterol Nutr. 2019;68:428–41.CrossRefPubMed Hyer W, Cohen S, Attard T, et al. Management of Familial Adenomatous Polyposis in Children and Adolescents: Position Paper From the ESPGHAN Polyposis Working Group. J Pediatr Gastroenterol Nutr. 2019;68:428–41.CrossRefPubMed
7.
go back to reference Arvanitis ML, Jagelman DG, Fazio VW, et al. Mortality in patients with familial adenomatous polyposis. Dis Colon Rectum. 1990;33:639–42.CrossRefPubMed Arvanitis ML, Jagelman DG, Fazio VW, et al. Mortality in patients with familial adenomatous polyposis. Dis Colon Rectum. 1990;33:639–42.CrossRefPubMed
8.
9.
go back to reference Grover S, Kastrinos F, Steyerberg EW, et al. Prevalence and phenotypes of APC and MUTYH mutations in patients with multiple colorectal adenomas. JAMA. 2012;308:485–92.CrossRefPubMedPubMedCentral Grover S, Kastrinos F, Steyerberg EW, et al. Prevalence and phenotypes of APC and MUTYH mutations in patients with multiple colorectal adenomas. JAMA. 2012;308:485–92.CrossRefPubMedPubMedCentral
10.
go back to reference Jagelman DG, DeCosse JJ, Bussey HJ. Upper gastrointestinal cancer in familial adenomatous polyposis. Lancet. 1988;1:1149–51.CrossRefPubMed Jagelman DG, DeCosse JJ, Bussey HJ. Upper gastrointestinal cancer in familial adenomatous polyposis. Lancet. 1988;1:1149–51.CrossRefPubMed
11.
go back to reference Iwama T, Mishima Y, Utsunomiya J. The impact of familial adenomatous polyposis on the tumorigenesis and mortality at the several organs. Its rational treatment Ann Surg. 1993;217:101–8.PubMed Iwama T, Mishima Y, Utsunomiya J. The impact of familial adenomatous polyposis on the tumorigenesis and mortality at the several organs. Its rational treatment Ann Surg. 1993;217:101–8.PubMed
12.
go back to reference Tomita N, Ishida H, Tanakaya K, et al. Japanese Society for Cancer of the Colon and Rectum (JSCCR) guidelines 2020 for the Clinical Practice of Hereditary Colorectal Cancer. Int J Clin Oncol. 2021;26:1353–419.CrossRefPubMedPubMedCentral Tomita N, Ishida H, Tanakaya K, et al. Japanese Society for Cancer of the Colon and Rectum (JSCCR) guidelines 2020 for the Clinical Practice of Hereditary Colorectal Cancer. Int J Clin Oncol. 2021;26:1353–419.CrossRefPubMedPubMedCentral
13.
go back to reference Park JG, Park KJ, Ahn YO, et al. Risk of gastric cancer among Korean familial adenomatous polyposis patients. Report of three cases. Dis Colon Rectum. 1992;35:996–8.CrossRefPubMed Park JG, Park KJ, Ahn YO, et al. Risk of gastric cancer among Korean familial adenomatous polyposis patients. Report of three cases. Dis Colon Rectum. 1992;35:996–8.CrossRefPubMed
14.
go back to reference Yamaguchi T, Ishida H, Ueno H, et al. Upper gastrointestinal tumours in Japanese familial adenomatous polyposis patients. Jpn J Clin Oncol. 2016;46:310–5.CrossRefPubMedPubMedCentral Yamaguchi T, Ishida H, Ueno H, et al. Upper gastrointestinal tumours in Japanese familial adenomatous polyposis patients. Jpn J Clin Oncol. 2016;46:310–5.CrossRefPubMedPubMedCentral
16.
go back to reference Kawai K, Nozawa H, Sasaki K, et al. Hazard function analysis for development of second primary colorectal cancer after surgery for primary colorectal cancer. J Gastroenterol Hepatol. 2022;37:56–62.CrossRefPubMed Kawai K, Nozawa H, Sasaki K, et al. Hazard function analysis for development of second primary colorectal cancer after surgery for primary colorectal cancer. J Gastroenterol Hepatol. 2022;37:56–62.CrossRefPubMed
17.
go back to reference Kumamoto K, Ishida H, Tomita N. Recent Advances and Current Management for Desmoid Tumor Associated with Familial Adenomatous Polyposis. J Anus Rectum Colon. 2023;7:38–51.CrossRefPubMedPubMedCentral Kumamoto K, Ishida H, Tomita N. Recent Advances and Current Management for Desmoid Tumor Associated with Familial Adenomatous Polyposis. J Anus Rectum Colon. 2023;7:38–51.CrossRefPubMedPubMedCentral
19.
go back to reference Miyaki M, Yamaguchi T, Iijima T, et al. Difference in characteristics of APC mutations between colonic and extracolonic tumors of FAP patients: variations with phenotype. Int J Cancer. 2008;122:2491–7.CrossRefPubMed Miyaki M, Yamaguchi T, Iijima T, et al. Difference in characteristics of APC mutations between colonic and extracolonic tumors of FAP patients: variations with phenotype. Int J Cancer. 2008;122:2491–7.CrossRefPubMed
20.
go back to reference Sample DC, Samadder NJ, Pappas LM, et al. Variables affecting penetrance of gastric and duodenal phenotype in familial adenomatous polyposis patients. BMC Gastroenterol. 2018;18:115.CrossRefPubMedPubMedCentral Sample DC, Samadder NJ, Pappas LM, et al. Variables affecting penetrance of gastric and duodenal phenotype in familial adenomatous polyposis patients. BMC Gastroenterol. 2018;18:115.CrossRefPubMedPubMedCentral
21.
go back to reference Uemura N, Okamoto S, Yamamoto S, et al. Helicobacter pylori infection and the development of gastric cancer. N Engl J Med. 2001;345:784–9.CrossRefPubMed Uemura N, Okamoto S, Yamamoto S, et al. Helicobacter pylori infection and the development of gastric cancer. N Engl J Med. 2001;345:784–9.CrossRefPubMed
22.
go back to reference Ito M, Sugiyama A, Mino M, et al. Prevalence of Helicobacter pylori infection in the general population evaluated by a resident-register-based epidemiological study. J Gastroenterol. 2022;57:540–6.CrossRefPubMed Ito M, Sugiyama A, Mino M, et al. Prevalence of Helicobacter pylori infection in the general population evaluated by a resident-register-based epidemiological study. J Gastroenterol. 2022;57:540–6.CrossRefPubMed
23.
go back to reference Hamashima C, Systematic Review G. Guideline Development Group for Gastric Cancer Screening G. Update version of the Japanese Guidelines for Gastric Cancer Screening. Jpn J Clin Oncol. 2018;48:673–83.CrossRefPubMed Hamashima C, Systematic Review G. Guideline Development Group for Gastric Cancer Screening G. Update version of the Japanese Guidelines for Gastric Cancer Screening. Jpn J Clin Oncol. 2018;48:673–83.CrossRefPubMed
25.
go back to reference Kunnathu ND, Mankaney GN, Leone PJ, et al. Worrisome endoscopic feature in the stomach of patients with familial adenomatous polyposis: the proximal white mucosal patch. Gastrointest Endosc. 2018;88:569–70.CrossRefPubMed Kunnathu ND, Mankaney GN, Leone PJ, et al. Worrisome endoscopic feature in the stomach of patients with familial adenomatous polyposis: the proximal white mucosal patch. Gastrointest Endosc. 2018;88:569–70.CrossRefPubMed
26.
go back to reference Shimamoto Y, Ishiguro S, Takeuchi Y, et al. Gastric neoplasms in patients with familial adenomatous polyposis: endoscopic and clinicopathologic features. Gastrointest Endosc. 2021;94(1030–42): e2. Shimamoto Y, Ishiguro S, Takeuchi Y, et al. Gastric neoplasms in patients with familial adenomatous polyposis: endoscopic and clinicopathologic features. Gastrointest Endosc. 2021;94(1030–42): e2.
27.
go back to reference Nakano K, Kawachi H, Chino A, et al. Phenotypic variations of gastric neoplasms in familial adenomatous polyposis are associated with endoscopic status of atrophic gastritis. Dig Endosc. 2020;32:547–56.CrossRefPubMed Nakano K, Kawachi H, Chino A, et al. Phenotypic variations of gastric neoplasms in familial adenomatous polyposis are associated with endoscopic status of atrophic gastritis. Dig Endosc. 2020;32:547–56.CrossRefPubMed
28.
go back to reference Koseki K, Takizawa T, Koike M, et al. Distinction of differentiated type early gastric carcinoma with gastric type mucin expression. Cancer. 2000;89:724–32.CrossRefPubMed Koseki K, Takizawa T, Koike M, et al. Distinction of differentiated type early gastric carcinoma with gastric type mucin expression. Cancer. 2000;89:724–32.CrossRefPubMed
29.
go back to reference Martin I, Roos VH, Anele C, et al. Gastric adenomas and their management in familial adenomatous polyposis. Endoscopy. 2021;53:795–801.CrossRefPubMed Martin I, Roos VH, Anele C, et al. Gastric adenomas and their management in familial adenomatous polyposis. Endoscopy. 2021;53:795–801.CrossRefPubMed
30.
go back to reference Kamiya T, Morishita T, Asakura H, et al. Long-term follow-up study on gastric adenoma and its relation to gastric protruded carcinoma. Cancer. 1982;50:2496–503.CrossRefPubMed Kamiya T, Morishita T, Asakura H, et al. Long-term follow-up study on gastric adenoma and its relation to gastric protruded carcinoma. Cancer. 1982;50:2496–503.CrossRefPubMed
31.
go back to reference Matsubara T, Beppu N, Ikeda M, et al. Current clinical practice for familial adenomatous polyposis in Japan: A nationwide multicenter study. Ann Gastroenterol Surg. 2022;6:778–87.CrossRefPubMedPubMedCentral Matsubara T, Beppu N, Ikeda M, et al. Current clinical practice for familial adenomatous polyposis in Japan: A nationwide multicenter study. Ann Gastroenterol Surg. 2022;6:778–87.CrossRefPubMedPubMedCentral
Metadata
Title
Risk of gastric adenoma and adenocarcinoma in patients with familial adenomatous polyposis in Japan: a nationwide multicenter study
Authors
Kazuhito Sasaki
Kazushige Kawai
Hiroaki Nozawa
Soichiro Ishihara
Hideyuki Ishida
Keiichiro Ishibashi
Yoshiko Mori
Satoki Shichijo
Yasuhiro Tani
Yoji Takeuchi
Akiko Chino
Misato Takao
Kenji Fujiyoshi
Takaaki Matsubara
Yasuyuki Miyakura
Fumitaka Taniguchi
Tatsuro Yamaguchi
Kohji Tanakaya
Naohiro Tomita
Yoichi Ajioka
Publication date
23-01-2024
Publisher
Springer Nature Singapore
Published in
Journal of Gastroenterology / Issue 3/2024
Print ISSN: 0944-1174
Electronic ISSN: 1435-5922
DOI
https://doi.org/10.1007/s00535-023-02074-8

Other articles of this Issue 3/2024

Journal of Gastroenterology 3/2024 Go to the issue

Acknowledgements

Acknowledgements

Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.